Register entry
PF PRISM CV
- Registered sites
- 0
- Drug products
- 0
- Live patents
- 59
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
59Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| BOSULIF | BOSUTINIB MONOHYDRATE | Nov 2026 |
| BOSULIF | BOSUTINIB MONOHYDRATE | May 2027 |
| BOSULIF | BOSUTINIB MONOHYDRATE | Feb 2034 |
| BOSULIF | BOSUTINIB MONOHYDRATE | Aug 2034 |
| INLYTA | AXITINIB | Dec 2030 |
| INLYTA | AXITINIB | Jun 2031 |
| INLYTA | AXITINIB | Feb 2035 |
| INLYTA | AXITINIB | Aug 2035 |
| INLYTA | AXITINIB | Jan 2037 |
| INLYTA | AXITINIB | Jul 2037 |
| PRISTIQ | DESVENLAFAXINE SUCCINATE | Jul 2027 |
| TORISEL | TEMSIROLIMUS | May 2032 |
| TORISEL | TEMSIROLIMUS | Nov 2032 |
| TYGACIL | TIGECYCLINE | Oct 2028 |
| TYGACIL | TIGECYCLINE | Feb 2029 |
| TYGACIL | TIGECYCLINE | Oct 2030 |
| XALKORI | CRIZOTINIB | May 2027 |
| XALKORI | CRIZOTINIB | Oct 2029 |
| XALKORI | CRIZOTINIB | Nov 2029 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.